|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/22 | (2006.01) |
| A61K 31/66 | (2013.01) | ||
| A61P 35/04 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/04 | (2018.01) | ||
| A61K 31/66 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| C07F 9/50 | (2006.01) | ||
| A61K 45/06 | (2006.01) |
| (11) | Number of the document | 3713559 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18880479.3 |
| Date of filing the European patent application | 2018-11-21 | |
| (97) | Date of publication of the European application | 2020-09-30 |
| (45) | Date of publication and mention of the grant of the patent | 2023-06-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2018/062174 |
| Date | 2018-11-21 |
| (87) | Number | WO 2019/104115 |
| Date | 2019-05-31 |
| (30) | Number | Date | Country code |
| 201762590432 P | 2017-11-24 | US |
| (72) |
LISANTI, Michael, P. , US
SOTGIA, Federica , CA
|
| (73) |
Lunella Biotech, Inc. ,
145 Richmond Road, Ottawa, ON K1Z 1A1,
CA
|
| (54) | TRIPHENYLPHOSPHONIUM COMPOUNDS FOR USE IN PREVENTING OR TREATING TUMOR RECURRENCE, METASTASIS AND RADIOTHERAPY RESISTANCE OR FOR TREATING CANCER |
| TRIPHENYLPHOSPHONIUM COMPOUNDS FOR USE IN PREVENTING OR TREATING TUMOR RECURRENCE, METASTASIS AND RADIOTHERAPY RESISTANCE OR FOR TREATING CANCER |